Latest California Healthline Stories
Always Connected With Thousands Of ‘Friends’ — Yet Feeling All Alone
Millennials and Gen Zers say they often feel isolated even when surrounded by friends — both real and virtual.
New Health Plans Expose The Insured To More Risk
Well-known insurers are offering plans with lower premiums. But they could leave patients on the hook for unexpected costs.
Trump’s Budget Offers $291M To Fight HIV In U.S. But Trims Overseas Efforts
The budget would increase funding for efforts like the state-centered initiatives run by the Centers for Disease Control and the Ryan White Program, which offers services and treatment to patients. But it would also dramatically cut funding for global HIV efforts.
‘Medieval’ Diseases Flare As Unsanitary Living Conditions Proliferate
Outbreaks of infectious diseases such as typhus and hepatitis A are resurging in California and around the country, particularly among homeless populations. Public health officials warn that such diseases could spread broadly.
How Much Difference Will Eli Lilly’s Half-Price Insulin Make?
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Military Doctors In Crosshairs Of A Budget Battle
Details of the reductions have not yet been announced, but in 2017 Congress ordered mandated changes to make the military health system more efficient.
FDA Announces Sweeping Plan To Review Safety Of Surgical Staplers
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.
As Hospitals Post Price Lists, Consumers Are Asked To Check Up On Them
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
Lawmakers United Against High Drug Prices Bare Partisan Teeth
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Podcast: ‘What The Health?’ What’s Next For The FDA?
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.